PE20050221A1 - Derivados de 3-(benzoilureido)-tiofeno sustituidos y procedimiento para su preparacion - Google Patents
Derivados de 3-(benzoilureido)-tiofeno sustituidos y procedimiento para su preparacionInfo
- Publication number
- PE20050221A1 PE20050221A1 PE2004000163A PE2004000163A PE20050221A1 PE 20050221 A1 PE20050221 A1 PE 20050221A1 PE 2004000163 A PE2004000163 A PE 2004000163A PE 2004000163 A PE2004000163 A PE 2004000163A PE 20050221 A1 PE20050221 A1 PE 20050221A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- phenyl
- coo
- benzoylureide
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
- C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10306502A DE10306502B4 (de) | 2003-02-17 | 2003-02-17 | Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050221A1 true PE20050221A1 (es) | 2005-04-04 |
Family
ID=32841675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004000163A PE20050221A1 (es) | 2003-02-17 | 2004-02-17 | Derivados de 3-(benzoilureido)-tiofeno sustituidos y procedimiento para su preparacion |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1597247B1 (enExample) |
| JP (1) | JP4589301B2 (enExample) |
| KR (1) | KR20050105470A (enExample) |
| CN (1) | CN1751036A (enExample) |
| AR (1) | AR043179A1 (enExample) |
| AT (1) | ATE402160T1 (enExample) |
| AU (1) | AU2004212054A1 (enExample) |
| BR (1) | BRPI0407552A (enExample) |
| CA (1) | CA2516269A1 (enExample) |
| CO (1) | CO5690549A2 (enExample) |
| DE (2) | DE10306502B4 (enExample) |
| HR (1) | HRP20050715A2 (enExample) |
| MA (1) | MA27657A1 (enExample) |
| MX (1) | MXPA05008331A (enExample) |
| NO (1) | NO20054168L (enExample) |
| PE (1) | PE20050221A1 (enExample) |
| PL (1) | PL376753A1 (enExample) |
| RU (1) | RU2005129109A (enExample) |
| TW (1) | TW200505892A (enExample) |
| WO (1) | WO2004072060A1 (enExample) |
| ZA (1) | ZA200505487B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006053274A2 (en) | 2004-11-15 | 2006-05-18 | Bristol-Myers Squibb Company | 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| WO2006055463A2 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| WO2006055462A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| US7223786B2 (en) | 2004-11-15 | 2007-05-29 | Bristol-Myers Squibb Company | 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| JP2008536932A (ja) * | 2005-04-18 | 2008-09-11 | サイード・アール・カーン | チューブリン重合阻害剤：ボンゾイルフェニル尿素（ｂｐｕ）硫黄類似体の設計及び合成 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| CA3144848C (en) * | 2019-06-28 | 2023-11-21 | Pfizer Inc. | 5-(thiophen-2-yl)-1h-tetrazole derivatives as bckdk inhibitors useful for treating various diseases |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3034004A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| HUT48880A (en) * | 1987-07-20 | 1989-07-28 | Sandoz Ag | Insecticides and acaricides comprising new n-benzoyl-n'-thienyl urea derivative as active ingredient and process for producing the active ingredients |
| EP1294682B1 (de) * | 2000-06-09 | 2004-04-28 | Aventis Pharma Deutschland GmbH | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE10116768A1 (de) * | 2001-04-04 | 2002-10-10 | Aventis Pharma Gmbh | Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10215908B4 (de) * | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
| DE10215907A1 (de) * | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| DE10225635C1 (de) * | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| MXPA05000055A (es) * | 2002-07-11 | 2005-04-08 | Aventis Pharma Gmbh | Acilureas sustituidas con urea y uretano, metodos para su produccion y su uso. |
| ATE452879T1 (de) * | 2002-07-12 | 2010-01-15 | Sanofi Aventis Deutschland | Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE10246434B4 (de) * | 2002-10-04 | 2005-08-04 | Aventis Pharma Deutschland Gmbh | Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel |
-
2003
- 2003-02-17 DE DE10306502A patent/DE10306502B4/de not_active Expired - Fee Related
-
2004
- 2004-02-04 KR KR1020057015029A patent/KR20050105470A/ko not_active Withdrawn
- 2004-02-04 DE DE502004007668T patent/DE502004007668D1/de not_active Expired - Lifetime
- 2004-02-04 AU AU2004212054A patent/AU2004212054A1/en not_active Abandoned
- 2004-02-04 EP EP04707896A patent/EP1597247B1/de not_active Expired - Lifetime
- 2004-02-04 WO PCT/EP2004/000993 patent/WO2004072060A1/de not_active Ceased
- 2004-02-04 AT AT04707896T patent/ATE402160T1/de not_active IP Right Cessation
- 2004-02-04 CN CNA2004800044004A patent/CN1751036A/zh active Pending
- 2004-02-04 JP JP2006501724A patent/JP4589301B2/ja not_active Expired - Fee Related
- 2004-02-04 PL PL376753A patent/PL376753A1/pl not_active Application Discontinuation
- 2004-02-04 HR HR20050715A patent/HRP20050715A2/xx not_active Application Discontinuation
- 2004-02-04 CA CA002516269A patent/CA2516269A1/en not_active Abandoned
- 2004-02-04 RU RU2005129109/04A patent/RU2005129109A/ru not_active Application Discontinuation
- 2004-02-04 MX MXPA05008331A patent/MXPA05008331A/es not_active Application Discontinuation
- 2004-02-04 BR BRPI0407552-8A patent/BRPI0407552A/pt not_active IP Right Cessation
- 2004-02-13 TW TW093103411A patent/TW200505892A/zh unknown
- 2004-02-13 AR ARP040100457A patent/AR043179A1/es unknown
- 2004-02-17 PE PE2004000163A patent/PE20050221A1/es not_active Application Discontinuation
-
2005
- 2005-07-07 ZA ZA200505487A patent/ZA200505487B/en unknown
- 2005-08-12 CO CO05080324A patent/CO5690549A2/es not_active Application Discontinuation
- 2005-08-16 MA MA28443A patent/MA27657A1/fr unknown
- 2005-09-07 NO NO20054168A patent/NO20054168L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE502004007668D1 (de) | 2008-09-04 |
| PL376753A1 (pl) | 2006-01-09 |
| AR043179A1 (es) | 2005-07-20 |
| DE10306502B4 (de) | 2005-03-17 |
| JP4589301B2 (ja) | 2010-12-01 |
| RU2005129109A (ru) | 2006-01-27 |
| CO5690549A2 (es) | 2006-10-31 |
| CN1751036A (zh) | 2006-03-22 |
| ATE402160T1 (de) | 2008-08-15 |
| AU2004212054A1 (en) | 2004-08-26 |
| NO20054168D0 (no) | 2005-09-07 |
| ZA200505487B (en) | 2006-08-30 |
| JP2006517933A (ja) | 2006-08-03 |
| KR20050105470A (ko) | 2005-11-04 |
| MA27657A1 (fr) | 2005-12-01 |
| WO2004072060A1 (de) | 2004-08-26 |
| CA2516269A1 (en) | 2004-08-26 |
| EP1597247B1 (de) | 2008-07-23 |
| HRP20050715A2 (en) | 2006-09-30 |
| DE10306502A1 (de) | 2004-09-09 |
| EP1597247A1 (de) | 2005-11-23 |
| MXPA05008331A (es) | 2005-09-30 |
| NO20054168L (no) | 2005-11-11 |
| TW200505892A (en) | 2005-02-16 |
| BRPI0407552A (pt) | 2006-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080906A1 (es) | Derivados heteroarilo como inhibidores de citocina | |
| DE60129712D1 (de) | Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten | |
| NO20060823L (no) | Benzimidazol, benztiazol og benzoksazol derivater og deres anvendelse som LTA4H modulatorer | |
| PE20040898A1 (es) | Nuevos compuestos derivados de pirimidina | |
| PE20060693A1 (es) | Nuevos derivados de trifluorometansulfonanilida oxamida eter | |
| RU2013119129A (ru) | Органические соединения | |
| AR045173A1 (es) | Compuestos que poseen actividad inhibitoria contra transportador de glucosa dependiente de sodio | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| RU2203274C2 (ru) | Спироциклические ингибиторы металлопротеаз | |
| PE20040374A1 (es) | DERIVADOS DE ACIL-4-CARBOXIFENILUREA COMO INHIBIDORES DE LA GLUCOGENO FOSFORILASA a | |
| RU2011106374A (ru) | Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1 | |
| AR032781A1 (es) | Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen | |
| CO5611139A2 (es) | Pirimidinas aril sustituidas y el uso de las mismas | |
| PE20110806A1 (es) | Compuestos derivados de benzofurano activos contra el virus de la hepatitis c | |
| DK419086D0 (da) | Heterocykliske substituerede indoler, mellemprodukter, fremgangsmaader til fremstilling heraf og laegemidler | |
| PE20070545A1 (es) | Derivados de fenil-[1,2,4]-oxadiazol-5-ona con grupo fenilo como agentes moduladores de ppar, composiciones farmaceuticas que los contienen y procedimientos para su preparacion | |
| PE20051173A1 (es) | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 | |
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| TW200608969A (en) | Heterocyclic boronic acid compounds | |
| PE20080267A1 (es) | Compuestos triarilicos y sus derivados | |
| CA2503117A1 (en) | Substituted 4-alkoxyoxazol derivatives as ppar agonists | |
| CO5640098A2 (es) | Acidos biariloximetilaren-carboxilicos | |
| PE20030718A1 (es) | Lactamas como antagonistas de taquiquininas | |
| AR046244A1 (es) | Activadores de glucoquinasa heteroaromaticos de seis miembros 5- sustituidos | |
| AR052330A1 (es) | Derivados de adamantano que comprenden quinoleinas sustituidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |